Episode 7: Giovanni Amabile, PhD, CEO of Enthera, Developing first-in-class biologics for type 1 diabetes
2020-08-23
In this episode, Giovanni Amabile joins Monica Westley to discuss the future of Enthera. Enthera is a biotech company building a pipeline of first-in-class biologics for several autoimmune conditions, with a focus in type 1 diabetes and inflammatory bowel disease.
More Episodes
Episode 143: William Rust, PhD, Seraxis
2022-07-27
131
2022-07-27
131
Episode 142: Shmuel Levit, MD, PhD, LEVICURE
2022-07-26
133
2022-07-26
133
Episode 139: Remi Creusot, PhD, Columbia
2022-07-25
114
2022-07-25
114
Episode 137: Andres Garcia, PhD, Georgia Tech
2022-07-09
132
2022-07-09
132
Episode 133: Elad Sintov, PhD, Harvard
2022-07-08
131
2022-07-08
131
Episode 132: Nayara Leite, PhD, Vertex Pharmaceuticals
2022-07-07
153
2022-07-07
153
Episode 131: Emrah Altindis, PhD, Boston College
2022-06-21
149
2022-06-21
149
Episode 130: Stephen Gray, PhD, Ourobionics
2022-05-03
163
2022-05-03
163
Episode 129: Jack Virostko, PhD, UT Austin
2022-04-28
139
2022-04-28
139
Episode 128: Ping Wang, PhD, Michigan State University
2022-04-26
139
2022-04-26
139
Episode 127: Abhishek Kulkarni, PhD, University of Chicago
2022-04-21
137
2022-04-21
137
Get this podcast on your
phone, FREE
